메뉴 건너뛰기




Volumn 89, Issue 4, 2002, Pages 327-336

Nitric oxide synthase gene therapy for cardiovascular disease

Author keywords

Cardiovascular disease; Gene therapy; Gene transfer; Nitric oxide synthase

Indexed keywords

ADENOVIRUS VECTOR; ANTICOAGULANT AGENT; ANTIHYPERTENSIVE AGENT; ARGININE; CALCIUM CHANNEL BLOCKING AGENT; CYCLIC GMP INHIBITOR; CYCLOSPORIN A; ISOPROTEIN; NITRIC OXIDE; NITRIC OXIDE DONOR; NITRIC OXIDE SYNTHASE; NITROPRUSSIDE SODIUM; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROSTACYCLIN; PROTEIN INHIBITOR; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1; VASODILATOR AGENT;

EID: 0036672483     PISSN: 00215198     EISSN: None     Source Type: Journal    
DOI: 10.1254/jjp.89.327     Document Type: Review
Times cited : (42)

References (86)
  • 67
    • 0029055964 scopus 로고
    • Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension
    • (1995) N Engl J Med , vol.333 , pp. 214-216
    • Giaid, A.1    Saleh, D.2
  • 72
    • 0031012401 scopus 로고    scopus 로고
    • The cellular pathogenesis of portal hypertension: Stellate cell contractility, endothelin, and nitric oxide
    • (1997) Hepatology , vol.25 , pp. 2-5
    • Rockey, D.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.